FAS and renal fibrosis: Fas, a selective Rho enzyme inhibitor, has been shown to have protective effects on renal fibrosis [17,18], and Fas can inhibit epithelial–myofibroblast transdifferentiation of renal tubular epithelial cells due to high sugar differentiation of renal tubular epithelial fibroblasts [19,20].